Insider · CIK 0001959360
Michael B Chancellor
Files at LIPO (LIPELLA PHARMACEUTICALS INC.). First filing -, latest -.
In brief
Michael B Chancellor files SEC Form 4 as officer, director and 10% owner at LIPO (LIPELLA PHARMACEUTICALS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael B Chancellor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +80,000 | $0.00 | $0 | 80,000 | Mar 19, 2024 |
| Mar 13, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | AGrant or award Common Stock | +144,906 | $0.69 | $100k | 877,637 | Mar 15, 2024 |
Questions about Michael B Chancellor
Answered from the filings on this page, as of the latest one.
Is Michael B Chancellor buying or selling?
Michael B Chancellor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael B Chancellor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael B Chancellor has 0.
Where does Michael B Chancellor file Form 4?
Michael B Chancellor has filed Form 4 at LIPO (LIPELLA PHARMACEUTICALS INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.